Lenampicillin
 | |
| Clinical data | |
|---|---|
| Trade names | Takacillin, Varacillin |
| Other names | KBT-1585 |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C21H23N3O7S |
| Molar mass | 461.49 g·mol−1 |
Lenampicillin is an antibiotic drug of the penicillin class. It is a produg of ampicillin; after oral administration of lenampicillin, ampicillin is rapidly formed.[1]
Lenampicillin inhibits bacterial penicillin binding proteins (transpeptidase) and is effective against a wide range of bacterial infections.[2]
Lenampicillin was developed in Japan and has been marketed there.[2]
References
[edit]- ^ Saito A, Nakashima M (May 1986). "Pharmacokinetic study of lenampicillin (KBT-1585) in healthy volunteers". Antimicrobial Agents and Chemotherapy. 29 (5): 948–950. doi:10.1128/aac.29.5.948. PMC 284190. PMID 3729355.
- ^ a b "Lenampicillin". InxightDrugs. National Center for Advancing Translational Sciences.
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.
Cover photo is available under {{::mainImage.info.license.name || 'Unknown'}} license.
Cover photo is available under {{::mainImage.info.license.name || 'Unknown'}} license.
Credit:
(see original file).
